- Home
- / Telo Genomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Telo Genomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$10.4 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating expense total | 4.5M | 1.1M | 1.3M | 1.3M | 2.1M | 2.8M | 2.7M | 2.7M |
| Depreciation and amortization | 124.0K | 57.0K | 33.0K | 40.0K | ||||
| EBITDA | (4.5M) | (1.1M) | (1.3M) | (1.3M) | (2.1M) | (2.8M) | (2.7M) | (2.7M) |
| EBIT | (4.6M) | (1.1M) | (1.3M) | (1.1M) | (2.1M) | (2.8M) | (2.7M) | (2.7M) |
| Interest income | 5.0K | |||||||
| Interest expense | 20.0K | 26.0K | ||||||
| Pre tax profit | (4.7M) | (1.1M) | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.7M) | (2.7M) |
| Net Income | (4.7M) | (1.1M) | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.7M) | (2.7M) |